Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis
- PMID: 28449692
- PMCID: PMC5406915
- DOI: 10.1186/s13075-017-1289-x
Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis
Abstract
Background: We examined models to predict disease activity transitions from moderate to low or severe and associated factors in patients with rheumatoid arthritis (RA).
Methods: Data from RA patients enrolled in the Corrona registry (October 2001 to August 2014) were analyzed. Clinical Disease Activity Index (CDAI) definitions were used for low (≤10), moderate (>10 and ≤22), and severe (>22) disease activity states. A Markov model for repeated measures allowing for covariate dependence was used to model transitions between three (low, moderate, severe) states and estimate population transition probabilities. Mean sojourn times were calculated to compare length of time in particular states. Logistic regression models were used to examine impacts of covariates (time between visits, chronological year, disease duration, age) on disease states.
Results: Data from 29,853 patients (251,375 visits) and a sub-cohort of 9812 patients (46,534 visits) with regular visits (every 3-9 months) were analyzed. The probability of moving from moderate to low or severe disease by next visit was 47% and 18%, respectively. Patients stayed in moderate disease for mean 4.25 months (95% confidence interval: 4.18-4.32). Transition probabilities showed 20% of patients with low disease activity moved to moderate or severe disease within 6 months; >35% of patients with moderate disease remained in moderate disease after 6 months. Results were similar for the regular-visit sub-cohort. Significant interactions with prior disease state were seen with chronological year and disease duration.
Conclusion: A substantial proportion of patients remain in moderate disease, emphasizing the need for treat-to-target strategies for RA patients.
Keywords: Clinical Disease Activity Index; Disease activity; Markov model; Prediction; Rheumatoid arthritis.
Figures

Similar articles
-
Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.Rheumatology (Oxford). 2017 Jul 1;56(7):1095-1101. doi: 10.1093/rheumatology/kex042. Rheumatology (Oxford). 2017. PMID: 28340006
-
Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry.J Rheumatol. 2015 Jul;42(7):1090-8. doi: 10.3899/jrheum.141043. Epub 2015 May 1. J Rheumatol. 2015. PMID: 25934829
-
Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry.Clin Exp Rheumatol. 2009 Jul-Aug;27(4):560-6. Clin Exp Rheumatol. 2009. PMID: 19772785
-
Databases of patients with early rheumatoid arthritis in the USA.Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S146-53. Clin Exp Rheumatol. 2003. PMID: 14969067 Review.
-
Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria.Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S129-32. Clin Exp Rheumatol. 2003. PMID: 14969064 Review.
Cited by
-
Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.JMIR Res Protoc. 2018 Jan 17;7(1):e15. doi: 10.2196/resprot.8794. JMIR Res Protoc. 2018. PMID: 29343461 Free PMC article.
-
Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan.Medicine (Baltimore). 2019 Oct;98(41):e17371. doi: 10.1097/MD.0000000000017371. Medicine (Baltimore). 2019. PMID: 31593087 Free PMC article.
-
Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis.Arthritis Res Ther. 2020 Oct 22;22(1):253. doi: 10.1186/s13075-020-02346-1. Arthritis Res Ther. 2020. PMID: 33092642 Free PMC article.
-
Modeling Posttreatment Prognosis of Skin Lesions in Patients With Psoriasis in China.JAMA Netw Open. 2023 Apr 3;6(4):e236795. doi: 10.1001/jamanetworkopen.2023.6795. JAMA Netw Open. 2023. PMID: 37022681 Free PMC article.
References
-
- Upchurch KS, Kay J. Evolution of treatment for rheumatoid arthritis. Rheumatology (Oxford) 2012;51 Suppl 6:vi28–36. - PubMed
-
- Kievit W, Fransen J, Adang EM, den Broeder AA, Bernelot Moens HJ, Visser H, van de Laar MA, van Riel PL. Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register. Rheumatology (Oxford) 2011;50(1):196–203. doi: 10.1093/rheumatology/keq325. - DOI - PubMed
-
- Uhlig T, Lie E, Norvang V, Lexberg AS, Rodevand E, Kroll F, Kalstad S, Olsen IC, Kvien TK. Achievement of remission and low disease activity definitions in patients with rheumatoid arthritis in clinical practice: Results from the NOR-DMARD Study. J Rheumatol. 2016;43(4):716–23. doi: 10.3899/jrheum.151132. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical